Current trends are driven by various strategic and financial considerations from both established pharmaceutical companies and development-stage biotech firms. Understanding the valuation and accounting implications of these transactions are crucial for stakeholders to navigate the complex landscape effectively.
A good outsourced partner can work alongside in-house accountants and stay on top of the moving target of healthcare accounting regulations, addressing tax risks and identifying cost-saving opportunities.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Providers must report how they spent funding received via the CARES Act by Sept. 30, but they are still grappling with questions related to what expenses need to be reported amid shifting government guidance.
Korea's news agency Yonhap reported that the executive, surnamed Lee, allegedly decided to tamper with evidence of a plot to inflate the value of Samsung's stake in a joint venture with a U.S. company.